Actively Recruiting

Phase Not Applicable
Age: 9Years - 17Years
All Genders
Healthy Volunteers
ID05988515

AI-Assisted Treatment for Residual Speech Sound Disorders in Children with Speech Sound Disorder

Led by Syracuse University · Updated on 2026-01-08

26

Participants Needed

1

Research Sites

N/A

Total Duration

On this page

Sponsors

S

Syracuse University

Lead Sponsor

N

National Institutes of Health (NIH)

Collaborating Sponsor

AI-Summary

What this Trial Is About

This research aims to find out how artificial intelligence (AI)-assisted home practice can improve learning the "r" sound for school-age children who have persistent speech sound disorders. The study focuses on children who have difficulty producing this sound and evaluates two different schedules of combining AI-led and human speech-language clinician-led treatments. The AI tool used is designed to detect mispronunciations and provide feedback, potentially increasing access to effective speech therapy despite clinician shortages. Participants receive a total of 5 weekly speech lessons with a human speech-language clinician via telepractice for 5 weeks. In addition, they are assigned to one of two groups: one group receives 3 AI-led speech sessions per week concurrently during the same 5 weeks as the human clinician sessions, while the other group receives the 3 AI-led sessions per week after the human clinician sessions have ended. The AI sessions are supervised by a caregiver and use a web-based software that analyzes speech accuracy and adjusts practice difficulty accordingly. During the study, participants will be assessed before treatment, after 5 weeks, and again at 10 weeks to measure changes in their accuracy producing the "r" sound in both practiced and unpracticed words. Evaluations include blinded listener ratings and surveys on social, emotional, and academic impacts. The study includes telepractice sessions, speech sound analysis, and caregiver involvement. The total study duration for participants is 10 weeks, with careful monitoring of speech improvement and retention.

CONDITIONS

Brief Title

AI-Assisted Treatment for Residual Speech Sound Disorders

Who Can Participate

Age: 9Years - 17Years
All Genders
Healthy Volunteers

Eligibility Criteria

Eligible

You may qualify if you...

  • Must speak a rhotic dialect of American English as a dominant language.
  • Must have begun learning English by at least the age of 3 years.
  • Must be between 9;0 to 17;11 years of age.
  • Must have reported difficulty with /r/ production.
  • Must have reported hearing within normal limits.
  • Must receive a Scaled Score of 5 or above on both the Listening Comprehension and Story Retelling subtests from the Test of Integrated Language & Literacy Skills (TILLS).
  • Must receive a percentile score of 8 or below on the Goldman-Fristoe Test of Articulation-3 (GFTA-3) Sounds in Words subtest.
  • Must have 1 scorable response with 5+ consecutive correct /pataka/ with > 3.4 syllables per second in the MRR-Tri task of the Maximum Performance Tasks OR must demonstrate no childhood apraxia of speech (CAS-only) features in BOTH articulatory and rate/prosody domains of the ProCAD.
  • Must score <40% accurate based on word-level items from our /r/ probe list.
  • Must score >=15% accuracy on /r/ on 45 syllables following Dynamic Assessment.
  • Must express interest in changing their /r/ production.
  • Must have oral structure and function that are appropriate for /r/ production.
  • Must have access to broadband internet with videoconferencing capabilities
Not Eligible

You will not qualify if you...

  • Must have no known history of autism spectrum disorder, Down Syndrome, cerebral palsy, intellectual disability, permanent hearing loss, epilepsy/antiepileptic medication, or brain injury/neurosurgery/stroke.
  • Must not have diagnosis of attention deficit disorder, attention deficit hyperactivity disorder, Tourette's, or Obsessive-compulsive disorder.
  • Must have no orthodontic appliances that block the roof of the mouth (e.g., palate expanders).
  • Must not have current cleft palate, fluency disorder, or voice disorder.
  • Must not demonstrate childhood apraxia of speech (CAS-only) features in BOTH articulatory and rate/prosody domains of the ProCAD.

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person)

Outpatient Treatment

Duration - 5 weeks

Participants receive speech therapy sessions using either a human speech-language pathologist or an Artificial Intelligence clinician within an evidence-based motor learning framework to improve /r/ sound production.

5 weekly visits with a human clinician and up to 15 sessions with an AI clinician supervised by a caregiver, occurring 3 times per week

Follow-up

Duration - Up to 5 weeks after treatment ends

Participants are assessed to evaluate changes and retention in /r/ sound production and impacts on social, emotional, and academic well-being after treatment completion.

1 visit (in-person) 5 weeks after treatment

Trial Site Locations

Total: 1 location

1

Syracuse University

Syracuse, New York, United States, 13244

Actively Recruiting

Loading map...

Research Team

J

Jonathan Preston, PhD

N

Nina Benway, PhD

How is the study designed?

Study Type

INTERVENTIONAL

Masking

SINGLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Similar Trials

A Developmental Framework For Linking Phonological And Morph...

Developmental Language Disorder

Actively Recruiting

2 locations

Online Assessment and Enhancement of Auditory Perception for...

Speech Sound Disorder

Actively Recruiting

1 location

Communication in Children With or Without Biomedical Conditi...

Speech Sound Disorder

Actively Recruiting

1 location

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here